Mounting evidence from clinical studies has reported high serum resistin levels in patients with metabolically unhealthy obesity, hypertension, diabetes mellitus II, and renal and liver complications [98,100,101,102,103,104,105,106,107,108,109]. Here, RETN is linked to obesity due to melanocortin 4 receptor deficiency.